KIT and gastrointestinal stromal tumor: Briefly, HQP1351 showed potent inhibitory effect on the growth of GIST T1 cells harboring primary KIT mutations within exon 11, with IC50 values similar with ponatinib, sunitinib, regorafenib and imatinib.